Understanding of the biological pathogenesis of ccRCC has led us to identify that von Hippel-Lindau tumor suppressor (VHL)/hypoxia-inducible factor 2 alpha (HIF2α signaling plays a central role in its development. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.